As we complete this second issue of the ***American Journal of Preventive Cardiology (AJPC)***, the COVID-19 pandemic continues globally and is spreading faster in parts of the United States and other countries. We wish to honor healthcare workers throughout the world who have rearranged their lives to combat this deadly disease. This also includes a multitude of colleagues in the cardiovascular field, and the many members of the ***American Society for Preventive Cardiology (ASPC)*** who have been pivotal in helping to launch the ***AJPC*** during this difficult time in our global history. The editors are particularly grateful to Dr. Amit Khera, the outgoing ASPC President, for his unwavering support of the vision driving the birth of this Journal. A special thank you goes to Dr. Koos Admiraal, Business Development Manager with Elsevier, who believed in the concept of the ***AJPC*** since it was first presented to him and has been a staunch promoter of this worthwhile endeavor.

Published quarterly, The ***AJPC*** is the official journal the ***ASPC***. It publishes articles in the areas of prevention research, teaching, practice and policy. Original research and reviews are published on epidemiology and clinical studies on risk factors, behavioral and pharmacologic interventions aimed at the primary and secondary prevention of cardiovascular diseases and related conditions, as well as the promotion of individual and community cardiovascular health. The journal publishes both original research and review papers that address key pragmatic aspects of preventive cardiology, including primary and secondary prevention of cardio-metabolic conditions predisposing to ischemia, and preventive aspects of other cardiovascular issues such as valve disease, atrial fibrillation, and inherited cardiomyopathies. We also encourage the submission of papers that address educational and other initiatives and methods aimed at improving the ability of cardiologists and healthcare professionals to provide effective prevention measures in the clinic and as public health services. Finally, the ***AJPC*** publishes guidelines and official policy statements from the **ASPC**, review articles, media reviews, and editorials, as well as the abstracts accepted at the ASPC Annual Scientific Sessions.

We are encouraged by the impressive number of high-quality submissions from renowned research groups from around the world. This places the Journal on an excellent trajectory for impact factor determination, and on a fast track for indexing in Pub Med and Scopus.

With this second issue we are pleased to present four state-of-the-art reviews on topics of extreme timeliness and pragmatic interest: Female Specific Risk Enhancers, Johns Hopkins' ABC Approach to Cardiovascular Disease Prevention, Phenotypes of Hypertension, and Hypertension Guidelines in the Era of COVID-19. In addition, original contributions cover topics of Premature Coronary Artery Disease, Geographic Distribution of Mortality after Myocardial Infarction in France, Ischemic Heart Disease Burden in Women in India, and Cardiovascular Risk and Financial Hardship from Medical Bills among Non-Elderly Adults.

We continue to encourage submissions on all aspects of practical preventive cardiology, with additional emphasis on teaching and training methods, on the business of medicine, and on the state of the field in different countries.
